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Canine dilated cardiomyopathy: diffuse remodeling, focal lesions and the involvement of 
macrophages and new vessel formation 
 
Dilated cardiomyopathy (DCM) is one of the most common cardiac diseases of dogs. A 
detailed understanding of the disease process is still lacking, but myocardial inflammation 
and fibrosis are suspected to contribute. This study aimed to gain information on the 
pathogenesis of canine DCM, by evaluating myocardial histological changes alongside 
the transcription of remodelling markers. The myocardium of 17 dogs with DCM and 6 
control dogs was examined by histology, immunohistology, morphometry and reverse 
transcription-quantitative PCR. DCM hearts exhibited relatively subtle, but statistically 
significant diffuse quantitative changes: an increase in interstitial macrophages and 
interstitial fibrosis, and a reduced proportion of contractile tissue. These changes were 
associated with a significantly higher myocardial transcription of remodelling enzymes, 
cytokines and intracellular adhesion molecule (ICAM)-1. In addition to the diffuse 
changes, focal cell-rich lesions were observed. These comprised infiltrating macrophages, 
new vessels and fibrosis and were associated with cardiomyocyte degeneration. Both 
macrophages and cardiomyocytes were found to express functional markers, such as 
transforming growth factor-β and vascular endothelial growth factor. The present findings 
confirm that DCM hearts undergo diffuse myocardial remodelling processes to which 
both cardiomyocytes and macrophages might actively contribute.  
 
Keywords: dilated cardiomyopathy, dogs, histology, fibrosis, macrophages 
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Kanine dilatative Kardiomyopathie: diffuse Umbauprozesse, herdförmige Veränderungen 
und die Beteiligung von Makrophagen und der Bildung neuer Blutgefässe 
 
Die dilatative Kardiomyopathie (DCM) ist eine der häufigsten Herzerkrankungen des 
Hundes. Bis jetzt ist das Wissen zur Entstehung dieser Erkrankung begrenzt, es wird 
jedoch davon ausgegangen, dass Entzündung und Fibrose daran beteiligt sind. Das Ziel 
der vorgelegten Arbeit war es, durch detaillierte histologische und molekulare 
Untersuchungen zur Transkription von “Remodelling“-Markern Informationen zur 
Pathogenese der kaninen DCM zu erhalten. Es wurden Herzen von 17 Hunden mit DCM 
und 6 Kontrollhunden mittels Histologie, Immunhistologie, Morphometrie und 
quantitativer RT-PCR untersucht. Das DCM-Myokardium wies recht unauffällige, jedoch 
statistisch signifikante quantitative Veränderungen auf: eine erhöhte Zahl an 
Makrophagen im Interstitium, eine vermehrte interstitielle Fibrose sowie eine 
Verminderung des Anteils an kontraktilem Gewebe. Damit verbunden war eine 
signifikant erhöhte Transkription von Remodelling-Enzymen, Zytokinen und dem 
intracellular adhesion molecule (ICAM)-1. Ausserdem fanden sich teils mehrere 
zellreiche Herde mit infiltrierenden Makrophagen, neuen Gefässen und Fibrose sowie 
vereinzelten degenerierenden Kardiomyozyten. Sowohl Makrophagen als auch 
Kardiomyozyten zeigten eine Expression funktionaler Marker wie transforming growth 
factor-β und vascular endothelial growth factor. Die Ergebnisse der Studie bestätigen, 
dass DCM mit diffusen Umbauprozessen im Myokardium einhergeht, zu denen 
Kardiomyozyten und Makrophagen aktiv beizutragen scheinen.   
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Abstract 
Dilated cardiomyopathy (DCM) is among the most common cardiac diseases in dogs. Its 
pathogenesis is not yet fully understood, but myocardial remodeling and inflammation 
are suspected to be involved. The present study aimed to characterize the pathological 
processes in canine DCM, investigating morphological changes in association with the 
expression of relevant cytokines and remodeling markers. The myocardium of 17 dogs 
with DCM and 6 dogs without cardiac diseases was histologically evaluated, and 
selected cases were further examined by immunohistology, morphometry and reverse 
transcription-quantitative PCR. In DCM, the myocardium exhibited subtle, though 
statistically significant diffuse quantitative changes. These comprised increased 
interstitial collagen deposition and macrophage numbers, and an overall reduced 
proportion of contractile tissue. This was accompanied by a significant increase in 
myocardial transcription of intracellular adhesion molecule (ICAM)-1, inflammatory 
cytokines and remodeling enzymes. Laser microdissection showed that cardiomyocytes 
transcribed most relevant markers. In addition, multifocal cell-rich lesions, characterized 
by fibrosis, neovascularization, macrophage infiltration and cardiomyocyte degeneration, 
were seen. In these, macrophages were often found to express ICAM-1, transforming 
growth factor-β and vascular endothelial growth factor; the former two were also 
expressed by cardiomyocytes.  
These results confirm that DCM is associated with diffuse myocardial remodeling 
processes. The observed multifocal cell-rich lesions might result from reduced tissue 
perfusion. Macrophages and cardiomyocytes seem to actively contribute to these 
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processes, which ultimately lead to cardiac dilation and dysfunction. The precise role of 
the involved cells and the factors initiating the remodeling process still need to be 
identified. 
 
Keywords: dilated cardiomyopathy, dogs, fibrosis, histology, immunohistology, 
inflammation, macrophages, morphometry 
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Dilated cardiomyopathy (DCM) is the most common cardiac disease in large breed dogs 
and is characterized by cardiac chamber dilation, systolic dysfunction and, in some 
cases, ventricular arrhythmia, which is eventually followed by congestive heart failure 
and/or sudden death.39,49,53,57 The clinical diagnosis of DCM is based on 
echocardiographic findings, excluding other cardiac or systemic diseases and 
medications, such as treatment with anthracycline,35 that may induce similar 
changes.11,39,49,53 
Gross post mortem examination of the canine DCM heart reveals eccentric, primarily left 
ventricular hypertrophy and secondary left atrial dilation.11,53 The histological changes, 
however, appear not to be very specific and are usually reported as mild: variation in 
myocyte size, myocyte degeneration and necrosis, and myocardial fibrosis of variable 
extent have been described.4,13,29,44,56 According to the literature there are two distinct 
histological patterns which can predominate one over the other depending on the 
affected dog breed. The “fatty infiltration-degenerative” (FID) type, with myofiber 
degeneration, fibrosis and adipocyte infiltration, is mainly described in Boxers and 
Doberman Pinschers.54 The “attenuated wavy fiber” (AWF) type, which is characterized 
by myofiber atrophy with a long wavy appearance of fibers, is seen in several large and 
medium-sized breeds, including Boxers and Doberman Pinschers.54 More recent studies 
described further myocardial alterations, such as a change in the cardiomyocyte 
phenotype (reduced desmin expression) and an increase in vimentin-positive cells in the 
left atria, a mild mononuclear inflammatory infiltration in the interstitium of both atria and 
ventricles,28,29 and hypertrophy of coronary vessel walls.30 
Progress has also been made regarding the etiology of DCM, and genes associated with 
the disease are identified in Boxers, Doberman Pinschers and Irish Wolfhounds.40,41,45,49   
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Following numerous studies conducted on small and large experimental animal models 
of both cardiomyopathies and myocardial infarction,7,8,25 it is generally accepted that 
most pathological processes affecting the myocardium, including DCM, result in a 
sequence of structural and functional changes known as myocardial remodeling.8,48 
Myocardial remodeling is in general prompted by cardiomyocyte injury, followed by an 
inflammatory reaction that is mediated by different cell types including neutrophils, 
macrophages and lymphocytes, and regulated by several factors, i.e. pro-inflammatory 
cytokines, adhesion molecules and extracellular matrix degrading enzymes (e.g. matrix 
metalloproteinases, MMPs).1,19,48 Anti-inflammatory cytokines and growth factors such 
as transforming growth factor-β (TGF-β) are subsequently involved in the reparative 
phase, promoting differentiation of fibroblasts into myofibroblasts, and extracellular 
matrix deposition.5,9,19,20 However, this repair process can also result in excessive 
fibrosis.19 Although sharing common pathways, depending on the type and extent of the 
initiating injury, different cellular and extracellular components are involved and the 
outcome may vary.3,48 
Recent studies of our group confirmed increased myocardial transcription of 
inflammatory cytokines, MMPs and their inhibitors in dogs with cardiac diseases, 
suggesting a general activation of the inflammatory system in the myocardium in 
association with cardiac diseases.16,18 
We hypothesize that the inflammatory and remodeling processes that are postulated to 
occur in the myocardium in association with canine DCM have consistent 
histopathological correlates in addition to those changes described so far. Therefore, the 
aim of the present study was to thoroughly assess the myocardium of dogs with clinically 
and grossly confirmed DCM for any pathological features and potential quantitative 
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changes, to gain further information on the pathomechanisms underlying DCM. 
 
 
Materials and Methods 
Animals and Sample Collection  
The study was conducted on the hearts of 23 dogs: 17 dogs with DCM, and 6 dogs with 
diseases not involving the heart (control group) (Supplemental Tables S1 and S2). The 
dogs were all euthanized, except for dog 1.16, which suffered sudden death on a walk. 
Among the 17 dogs with DCM were ten Great Danes, six Doberman Pinschers and one 
Bullmastiff, they had a mean age of 6.4 years (range: 4 to 10 years). Nine dogs were 
female (4 of these were neutered) and 8 were male (of which 1 was neutered). The dogs 
in the control group represented various breeds and had a mean age of 7 years (range: 
0.5 to 11 years); each three were male and female neutered. 
At different time points prior to death, echocardiography had been carried out in all dogs 
with DCM to diagnose the disease, except for dog 1.16. For this dog, DCM was 
diagnosed on gross and histological cardiac findings during full necropsy. Further clinical 
investigations of the dogs with DCM had been performed on the discretion of the 
attending clinician (a board-certified cardiologist or a cardiology resident under direct 
supervision of a board-certified cardiologist), and included a complete blood count, 
biochemistry, electrocardiography and/or thoracic radiographs, depending on patient 
presentation. Dogs with non-cardiac diseases were euthanized on request of the owners 
due to grave prognoses (Supplemental Table S2). These dogs underwent investigations 
according to their presentation and based on the assessment of the attending clinician.  
Dogs underwent a partial (thoracic cavity) diagnostic post mortem examination with the 
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owners’ consent. Hearts were removed and grossly examined for any pathological 
changes. Samples were collected from left atrium (LA) and right atrium (RA), left 
ventricular free wall (LV), right ventricular free wall (RV), and interventricular septum 
(IVS) for histological examination and, in selected cases (4 DCM and all control dogs) 
for RNA extraction (Supplemental Table S1 and S2). To obtain the samples, the lower 
half of the heart was separated by a cross section, and a sample from each of the mid 
LV, IVS, and RV towards the heart base was obtained. One cross-sectional slice of the 
removed apex was processed for histology after fixation, 
in addition to longitudinal sections of the LV, IVS, and RV. To ensure optimal 
complementarity, samples for RNA extraction were collected next to these areas.  
 
Histological, Immunohistological and Fluorescence Examinations 
Myocardial samples were fixed in 10% neutral-buffered formalin and routinely paraffin 
wax embedded. Consecutive sections (3 - 5 µm) were prepared and routinely stained 
with hematoxylin eosin and the van Gieson (VG) stain for the demonstration of collagen 
deposition. In 15 DCM cases (Supplemental Table S1) and all control hearts, additional 
sections were subjected to immunohistological and fluorescence staining. 
The specimens were evaluated by light microscopy and assessed for any 
histopathological changes including those previously described in DCM, such as fatty 
infiltration, wavy fibers, fibrosis, and cardiomyocyte necrosis/degeneration.54  
Immunohistology was performed using a Dako autostainer (Dako, Glostrup, Denmark) or 
the Discovery XT autostainer (Ventana Medical System, Inc., Tucson, USA). It served to 
detect leukocytes (CD18+, MHC II+), specifically, T cells (CD3+), B cells (CD20+) and 
macrophages (calprotectin+, Iba-1+), blood vessels, i.e. vascular endothelial cells 
13 
 
(Factor VIII+, CD31+) and smooth muscle cells (α-smooth muscle actin (α-SMA)+), and 
relevant mediators, i.e. TGF-β1, vascular endothelial growth factor (VEGF) and its 
receptor (Flk-1), and intercellular adhesion molecule 1 (ICAM-1). Antibodies with antigen 
retrieval and detection methods are listed in Supplemental Table S3. Briefly, after 
deparaffination, antigen retrieval was performed for all antigens except for α-SMA and 
CD20, by incubation of the slides with citrate buffer (pH 6) at 98°C for 10 min, or with 
EDTA buffer (pH 9) at 98°C for 20 min. Endogenous peroxidase was blocked by 
incubation with hydrogen peroxide solution for 10 min. Sections were incubated with 
horse serum for 30 min at room temperature, followed by the primary antibodies and 
matching secondary antibodies; different detection kits were then applied. Sections were 
washed with phosphate buffered saline between each incubation step (pH 8). Finally, 
sections were counterstained with hematoxylin for 40 s and mounted.  
Consecutive sections incubated with an isotype-matched irrelevant antibody or without 
the primary antibody served as negative controls. A chronic inflammatory process with 
granulation tissue formation served as positive control tissue.  
The immunohistological staining was evaluated based on the morphology and location 
of the positive cells (vascular endothelial cells, smooth muscle cells in vessel wall, 
interstitial cells, lymphocytes and cardiomyocytes) as well as their distribution (scattered, 
multifocal or diffuse).   
A further section underwent fluorescence staining to mark cell nuclei, using the ProLong 
Diamond Antifade Mountant with DAPI (4', 6-diamidino-2-phenylindole; Invitrogen). 
Briefly, after deparaffination and rehydration, sections were incubated with DAPI for 24 h 
at room temperature in the dark and then mounted.  
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Histomorphometric Analysis  
Sections from RV, LV and IVS from 15 dogs with DCM (Supplemental Table S1) and 
from all control dogs (Supplemental Table S2) stained with the VG stain, for α-SMA, Iba-
1 and with DAPI fluorescence and exhibiting consistent staining quality throughout the 
entire section were scanned (NanoZoomer-XR C12000; Hamamatsu, Japan) to obtain 
high resolution digital images. These were subsequently analyzed with the Visiopharm 
Integrator System (VIS, version 4.5.1.324, Visiopharm, Hørsholm, Denmark), 
considering the following parameters: overall cell number (based on the number of 
DAPI-positive nuclei), percentage area occupied by collagen fibers (based on the 
percentage of VG positive fibers), number of interstitial macrophages and blood vessels 
(based on the number of Iba-1- and α-SMA-positive cells, respectively), and the 
respective proportion of tissue occupied by a) cardiomyocytes (interpreted as contractile 
tissue), b) collagen fibers, and c) fiber- and cell-free interstitial space (all assessed in the 
VG-stained section).   
To specify, for each section, regions of interest with a size of 0.237 mm2 (the area of a 
high power field with one ocular of 22 mm field of view) were randomly selected across 
the myocardium from areas free of focal cell-rich lesions. For DAPI, α-SMA and Iba-1 
and VG, positive cells and percentage of VG-positive fibers were counted in 20 regions 
of interest per section. In the VG-stained sections the areas comprised of a) 
cardiomyocytes, b) collagen fibers, and c) fiber- and cell-free interstitial space) were 
quantified within 10 regions of interest per section.  
 
Relative Quantification of Cytokine and Remodeling Marker Transcription 
From selected DCM cases (1.10, 1.11, 1.14, and 1.15; Supplemental Table S1) and the 
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control dogs (which were partly used in previous studies16,17) myocardial samples could 
be collected within 1 h after death. These were stored in RNAlater (Thermo Fisher, 
Waltham, MA, USA) at -20°C until further use. Reverse transcriptase quantitative PCR 
(RT-qPCR) was carried out as previously described.15 Published primer sequences were 
used for the canine housekeeping gene GAPDH, ICAM-1, cytokines (interleukin [IL]-1, -
6, -8, -10, TNF-, TGF-β), matrix metalloproteinase (MMP)-1, -2, -3, -9, -13, tissue 
inhibitor of MMP (TIMP)-1, -2, -3, -4, and lysyl oxidase.16,18,42 The relative transcription 
levels of all markers were calculated using GAPDH and the 2–ΔCt method, as previously 
reported; all dogs have been part of previous studies the results of which have been 
published in different contexts.16,18 From one dog with DCM (case 1.10) cardiomyocytes 
were collected using laser microdissection; RNA was extracted and qPCR was carried 
out as previously reported.16,18  
 
Statistical Analyses 
Statistical analysis was carried out using SPSS. Distribution of data obtained from 
histomorphometry and qPCR was analyzed applying graphical Q-Q plots, Kolmogorov 
Smirnov and Shapiro-Wilk tests. Data were not normally distributed for α-SMA, VG, 
ICAM-1, cytokines, MMP and TIMPs. Results from dogs with DCM and control dogs and 
results for different cardiac regions were therefore compared using Kruskal-Wallis and 
Mann Whitney U tests for not normal distributed data and 1-way ANOVA and unpaired t-
tests for normal distributed data. Statistical significance was defined as P < 0.05. 
 
 
 
16 
 
Results 
 
Study Population 
With a mean age of 6.4 (± 1.6) and 7 (± 3.6) years, respectively, dogs with DCM and 
control dogs were of similar age (p=0.531). Among the dogs with DCM, the 10 Great 
Danes had a mean age of 6 years (± 1.5) and were overall slightly younger than the six 
Doberman Pinschers, which had a mean age of 7 years (± 1.8). However, the age 
difference was not significant (p=0.247).  
 
Gross Findings 
Grossly, the hearts from dogs with DCM showed the previously reported macroscopic 
changes,11,53 including cardiomegaly and chamber dilation (primarily of LA and LV). The 
hearts of control dogs were macroscopically unremarkable. 
 
The DCM myocardium exhibits diffuse widening of the interstitium with increase in 
collagen deposition and macrophages, and relative reduction of the contractile tissue. 
All hearts were first screened for the presence of those histological features of DCM that 
are known from the literature.11,38,54 In 12 DCM cases (6/6 Doberman Pinschers, 5/10 
Great Danes, the Bullmastiff), changes consistent with the FID type were detected, in 
the LV and/or IVS, and in half of the cases (n=6; 4 Doberman Pinschers, 1 Great Dane 
and the Bullmastiff) also in the RA, RV or LA. Changes consistent with the AWF type, 
represented by multifocal areas with thin myofibers that showed a wavy appearance, 
were only detected in Great Danes (7/10), most frequently in the RA (n=5), followed by 
the RV (n=3), LV and IVS (each n=2). The results are listed in Supplemental Table S1. 
Neither change was observed in the control hearts. 
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In 5/17 DCM dogs (4 Great Danes and 1 Doberman Pinscher; 1.1, 1.2, 1.6, 1.10, 1.12) 
vascular changes, represented by mild media hypertrophy of intramural arteries were 
observed;13,30 a focal chronic mural thrombus was detected in the LA of one Great Dane 
(1.10).  
In comparison to the myocardium of the control dogs, the interstitium of the DCM 
myocardium appeared overall wider and more cellular (Figs. 1, 2). In most cases, this 
finding was most prominent in the LV and IVS. The interstitial cells were generally round 
to spindle shaped, with a moderate to high amount of cytoplasm and oval to round 
nuclei. Some were more slender and resembled fibroblasts, but did not appear 
associated with collagen deposition (Fig. 3). Regardless of their shape, the majority of 
these cells were identified as macrophages, as they were found to express Iba-1, CD18 
and MHC II (Fig. 4a-c). Interestingly, occasional intact cardiomyocytes distant from 
lesions exhibited strong cytoplasmic MHC II expression (data not shown). Calprotectin 
expression was observed in monocytes within vessel lumina and in occasional 
elongated interstitial cells, suggesting these had recently emigrated from the blood into 
the tissue.19 A small proportion of the spindle shaped cells showed α-SMA expression 
(Fig. 5a). Otherwise, α-SMA positive cells were seen to surround small blood vessels, as 
confirmed by the matching arrangement of endothelial cells (FVIII-related antigen+; Fig. 
5b); the latter were found to occasionally express Iba-1 and MHC II (Fig. 4a, c). 
Occasional individual T cells (CD3+) and B cells (CD20+) were also seen. 
Apart from the above-mentioned occasional “wavy fibers” and mild degenerative 
changes (rare loss of striation and scattered cytoplasmic vacuolization), the 
cardiomyocytes appeared unaltered.  
A morphometric approach was taken to substantiate the above findings. Assessment of 
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the control dogs showed that the unaltered myocardium exhibits a similar overall 
cellularity (DAPI+ nuclei), proportion of contractile tissue, interstitial width (optically 
empty space plus collagen fibers) as well as a similar amount of small vessels (α-SMA+ 
vascular structures) and macrophages (Iba-1+) in the interstitium in all examined cardiac 
regions (i.e. LV, RV, IVS; Table 1A).  
In DCM, the myocardium exhibited an overall significantly lower cellularity (DAPI+ 
nuclei) than in control dogs. This was coupled with a significant increase in the number 
of Iba-1+ interstitial macrophages and a significantly lower relative proportion of 
contractile tissue, as well as an increased proportion of both fiber- and cell-free 
interstitial space and interstitial collagen (Table 1B).  
A comparison of these parameters in the different cardiac regions (LV, RV, IVS) of dogs 
with DCM and control dogs confirmed these results. The proportion of fiber- and cell-free 
interstitial space was significantly increased and the proportion of contractile tissue 
significantly reduced in all three regions in DCM dogs (Table 1A). Similarly, DCM dogs 
also exhibited a decreased cellularity and an increase in interstitial collagen, but the 
difference was significant only in the LV and IVS. Interestingly, the amount of Iba-1+ 
interstitial macrophages was increased in both LV and IVS, but the difference was only 
significant in the LV (Table 1A). A comparison of the different cardiac regions in DCM 
showed also region-dependent differences for several parameters. The number of 
interstitial macrophages (Iba-1+) was significantly higher in the LV and IVS than in the 
RV. The interstitial collagen content was higher in the LV than in the IVS, whereas the 
proportion of contractile tissue (area covered by cardiomyocytes) was higher in the IVS 
than in the LV (Table 1A). 
There was no significant difference in the number of interstitial vessels (α-SMA+ 
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structures) between both groups of dogs and in the different cardiac regions in both 
groups (Table 1). 
 
The DCM myocardium exhibits focal lesions, representing areas of fibroblast and 
macrophage accumulation and new vessel formation  
In 14 DCM cases, focal to multifocal, occasionally coalescing lesions, ranging between 
approximately 0.1 and 5 mm in diameter (Fig. 6a), were found in addition to the diffuse 
changes. These consisted of focal expansion of the interstitium and replacement of 
cardiomyocytes by cell-rich infiltrates containing differentiated vessels and abundant 
round to elongate cells with a morphology similar to the interstitial cells described above 
(Fig. 6b). A large proportion of these cells were identified as macrophages (Iba-1+, 
CD18+, MHC II+) (Fig. 7a-c). However, staining for α-SMA revealed that the infiltrates 
also contained large amounts of small vessels (ranging in diameter between 
approximately 10 and 50 µm; Fig. 7d) which was confirmed by staining for FVIII-related 
antigen and CD31, both highlighting the inner ring of endothelial cells and the presence 
of a small vascular lumen. The endothelial cells were occasionally found to also express 
Iba-1 (Fig. 7a) and MHC II (Fig. 7c). Vessels clearly dominated in some areas of the 
lesions (Fig. 8). Collagen fibers were found in small amounts between the cells within 
the lesions and replacing or surrounding individual degenerated cardiomyocytes. They 
were generally thin and loosely arranged, rarely forming more mature, dense fibrous 
tissue deposits (Fig. 9). Residual cardiomyocytes entrapped within the lesions displayed 
degenerative changes (swollen and vacuolated sarcoplasm) or necrosis. When present, 
focal lesions were seen in at least one of the five examined areas of the heart, most 
frequently in the LV (12/17), IVS (6/17) and RA (5/17) (Supplemental Table S1). In the 
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control dogs, the myocardium did not exhibit any of the above described histological 
changes.  
 
The pathological changes in the DCM myocardium are associated with significant 
upregulation of cytokines and remodeling markers 
As previously described, the normal canine myocardium exhibits constitutive expression 
of cytokines and remodeling markers.16,18 In the present study we could show that this is 
also true for the adhesion molecule ICAM-1. In comparison, dogs with DCM showed 
significantly higher myocardial transcription of ICAM-1, TNF-α, IL-1, IL-8, IL-10, MMP-2, 
TIMP-1, and lysyl oxidase (Table 2). Laser microdissection with subsequent qPCR 
confirmed cardiomyocytes as a source of all markers tested with this approach, i.e. 
ICAM-1, TNF-α, IL-8, TGF-β, MMP-2, TIMP-1 and TIMP-2. For ICAM-1 and TGF-, 
immunohistology was also applied and confirmed that morphologically unaltered 
cardiomyocytes produce both proteins, at low (ICAM-1) and very low (TGF-β) level in 
control hearts, and moderately (ICAM-1) and weakly (TGF-β) in DCM (Figs. 10-15). 
VEGF and its receptor, Flk1, were not expressed in the myocardium of control dogs, and 
VEGF expression was not detected in cardiomyocytes in DCM either (Figs. 16, 17). 
However, Flk1 was consistently expressed by cardiomyocytes in DCM (Figs. 18, 19). 
ICAM-1, TGF- and VEGF were also expressed in a proportion of cells within the focal 
lesions, mainly with the morphology of macrophages (Figs. 12, 15, 17). Interestingly, the 
mononuclear cells in the interstitium were often strongly TGF-β positive (Fig. 14), but 
showed only weak ICAM-1 (Fig. 11) and neither VEGF nor Flk1 expression (Figs. 16, 
18). Endothelial cells of both intralesional and extralesional vessels occasionally showed 
weak ICAM-1, TGF-β, and Flk1 expression. A similar expression was seen occasionally 
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in vessels in the control hearts. 
 
 
Discussion 
The present study represents a detailed investigation into the pathological changes in 
canine DCM, a disease associated with cardiac remodeling and of so far largely 
unknown pathogenesis.30,48,52 Our results confirm a number of previously described 
histological changes as consistent features of canine DCM.54 The so-called FID type 
was primarily found in Doberman Pinschers and the Bullmastiff.54 These dogs did not 
show changes consistent with the AWF type. Great Danes on the other hand exhibited 
either FID or AWF changes, or both. Similar to previously published studies, these 
results suggest breed-dependent differences in the underlying pathogenesis or in the 
cardiomyocyte response to injury33,53,55, which might also be the cause of breed 
differences in clinical presentations.35,49,56 Interestingly, FID changes were found to 
affect both the left and right heart, whereas AWF changes were more prominent in the 
right (RA and RV); this differs from a previous study undertaken in several dog breeds 
that reported wavy fibers as most abundant in the LV.54 
Besides these known morphological features, the present study revealed more subtle 
diffuse myocardial changes in all DCM hearts, and, in addition, cell-rich focal lesions in a 
large proportion of cases, both without any relation to the presence of AWF or FID 
changes. To specify, the diffuse changes consisted of a relative reduction of the 
contractile tissue in association with an expansion of the interstitium due to an overall 
widening of the fiber- and cell-free space and an increase in the amount of interstitial 
collagen. Alongside this, an overall significantly reduced cellularity was observed despite 
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a significant increase in interstitial macrophages (Iba1+); this indicates that DCM is 
associated with loss of cardiomyocytes and thereby of contractile tissue.  
Taken together these findings point towards individual cardiomyocyte injury and loss as 
the initial pathogenic process. This suggests that canine DCM differs from human 
primary DCM where the overall cell number does not change and an increase in cardiac 
muscle mass is observed as a result of compensatory cardiomyocyte hypertrophy.2 
Further in depth studies would be required to confirm that canine DCM is indeed not 
associated with a change in cardiomyocyte size. 
The focal cell-rich lesions were found more or less randomly distributed in most (14/17) 
DCM hearts where they were most prevalent and intense in the LV, followed by the IVS. 
Macrophages (Iba-1+, CD18+, MHC II+) were also abundant in these lesions. Both here 
and in the interstitium, they could result from local proliferation of resident cardiac 
macrophages and from monocyte recruitment.23,27 Since calprotectin, a myeloid cell 
marker expressed by neutrophils, monocytes and recently blood derived, but not mature 
macrophages,19 was found to be expressed only rarely in myocardial macrophages, it is 
likely that the vast majority were tissue-resident macrophages or resulted from local 
proliferation of macrophages recruited at an earlier stage.33 Given the large 
heterogeneity of macrophage phenotypes and functions,11,18,21,21 it is not clear if 
macrophages involved in the response to cardiac injury have a pro-inflammatory role 
and contribute to adverse cardiac remodeling, or have instead a reparative and 
cardioprotective function.12,20,27 It has been postulated that resident macrophages are 
more likely to have a role in tissue repair processes in cardiac injury.12 However, in the 
present study, immunohistology showed that macrophages in the focal lesions 
expressed TGF-β, ICAM-1, VEGF, and, though less abundantly, its receptor, Flk1, 
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suggesting a dual function, i.e. both a reparative and an inflammatory role in canine 
DCM. In rats, ICAM-1, a cell adhesion molecule critical for leukocyte recruitment, 
mediates adhesion of macrophages to cardiomyocytes.6,45 Such macrophage adherence 
can result in decreased cardiomyocyte contractility via the expression of TNF-α, oxygen 
free radicals and nitric oxide.45 Laser microdissection with subsequent qPCR as well as 
immunohistology confirmed that cardiomyocytes produce ICAM-1, cytokines and 
remodeling enzymes. This suggests that both macrophages and cardiomyocytes might 
contribute to cardiomyocyte damage and/or dysfunction and the pathogenic process in 
dogs with DCM. ICAM-1 and cytokine upregulation also suggest an inflammatory state 
of the DCM myocardium. Inflammatory cytokines like TNF-α and IL-1, and chemokines 
regulate collagen turnover. These cytokines are involved in the dysregulation of MMP 
and TIMP expression8,10 and inhibition of collagen degradation. This contributes to 
fibrosis, as observed in the dogs with DCM, and to decreased myocardial contractility 
and progression of heart failure, as reported for human DCM.32,47,48 In particular, 
upregulation of MMP-2, TIMP-1 and TIMP-2 has been described in non-ischemic human 
DCM and in experimental conditions in dogs.36,37,46,52 which is similar to the increase of 
MMP-2 and TIMP-1 found in the DCM dogs. Furthermore, TGF-β that was expressed by 
cardiomyocytes as well as by lesional and interstitial macrophages might contribute to 
the increase in collagen observed in the DCM dogs. Cardiomyocytes under stress 
conditions or undergoing necrosis are known to be able to contribute to fibrosis through 
the production of TGF-β.22 TGF-β exerts pro-fibrotic effects through the proliferation and 
differentiation of fibroblasts into myofibroblasts,5,9,10 cells that were likely present both 
among the interstitial macrophage population and within the focal cell-rich lesions in the 
canine DCM myocardium.  
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In addition to the macrophage infiltration, the focal cell-rich lesions exhibited abundant 
small vessels indicative of neovascularization, whereas collagen deposition was limited. 
Individual degenerating/necrotic cardiomyocytes were found in the periphery of or 
entrapped within the lesions. The morphological evidence of neovascularization was 
associated with VEGF expression within infiltrating cells (most likely macrophages) in 
the lesions. These macrophages also produce TGF-β,26,55 which, next to hypoxia, further 
stimulates VEGF production.26,51  
Interestingly, the macrophages with higher pro-angiogenic potential have been shown to 
belong to the anti-inflammatory subset of macrophages and might therefore be involved 
in a repair attempt of the observed lesions.31 
We found evidence of substantial expression of the VEGF receptor Flk-1 by 
cardiomyocytes in DCM, with particular intensity in cardiomyocytes entrapped in the 
lesions. When binding to Flk-1, VEGF exerts its angiogenetic properties; this interaction 
might have further contributed to the observed new vessel formation.51 Morphologically, 
the focal lesions resemble chronic myocardial infarcts:14 infarct healing is associated, 
particularly in the dog, with an intense angiogenic response.7 Considering that we did 
not observe changes that would directly explain these lesions, and taking into account 
the described diffuse changes, it appears most likely that the focal lesions are a 
consequence of focal cardiomyocyte necrosis as a result of reduced tissue perfusion. 
The latter might be the result of the increased distance between blood vessels and 
cardiomyocytes due to interstitial edema (indicated by the overall widening of the 
interstitial space) and collagen deposition, or might also derive from the reduced oxygen 
tension characteristic of the microenvironment of a chronically inflamed tissue.50  
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In summary, canine DCM is associated with diffuse myocardial remodeling processes 
and focal lesions in the majority of dogs. Both macrophages and cardiomyocytes might 
actively contribute to the pathogenic process through the production of cytokines, 
adhesion molecules and remodeling enzymes, which eventually leads to cardiac dilation 
and impaired cardiac function.  
Interestingly, we found similar changes, i.e. generalized diffuse remodeling and focal 
lesions, with cardiomyocyte degeneration, increased fibrosis, macrophages and 
neovascularization in cats with hypertrophic cardiomyopathy, a disease with a very 
different phenotype.34 The resemblance of results suggests similar pathophysiological 
processes. Further investigations are required to explain how these processes result in 
diseases with different structural and functional presentations and which are the roles of 
macrophages and cardiomyocytes, which appear primarily involved in the pathogenesis 
of both canine DCM and feline hypertrophic cardiomyopathy.  
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Figure Legends 
 
Figure 1. Control heart, dog 2.3. Unaltered myocardium with tightly aligned 
cardiomyocytes. HE stain. Figures 2-5. DCM, heart, dog 1.15. Figure 2. The 
myocardium exhibits a widened interstitium with an increased amount of cells (arrow). 
HE stain. Figure 3. The interstitial cells (arrow) are round to spindle shaped, with an 
oval to round nucleus, sometimes more slender, resembling fibroblasts. HE stain. 
Figure 4. The majority of interstitial cells are macrophages, as they express Iba-1 (a), 
CD18 (b) and MHC II (c). Occasional endothelial cells in interstitial vessels are found to 
express Iba-1 (a) and/or MHC II (c). Immunohistology, hematoxylin counterstain. Figure 
5. The interstitium exhibits abundant small vessels, identified on the outer layer of α-
SMA positive cells (smooth muscle cells, arrows) (a) and the (inner), FVIII-related 
antigen positive endothelial cell layer (b). A small proportion of the spindle shaped cells 
in the interstitium also showed α-SMA expression (myofibroblasts; arrowheads) (a). 
Immunohistology, hematoxylin counterstain. 
Figures 6-9. DCM, heart, dog 1.15. Focal lesions. Figure 6. Focal replacement of 
cardiomyocytes by a cell-rich infiltrate (a; M: myocardium with unaltered cardiomyocytes. 
b. The infiltrate contains differentiated vessels (arrows) and abundant round to elongate 
cells with a morphology similar to the interstitial cells observed in increased numbers 
throughout the entire myocardium. HE stains. Figure 7. A large proportion of cells in the 
infiltrate are identified as macrophages, based on the expression of Iba-1 (a), CD18 (b) 
and MHC II (c), intermingled with and partly outnumbering the α-SMA positive cells that 
in the majority form small vessels (d). Occasional endothelial cells found to also express 
Iba-1 (a; arrowhead) and MHC II (c; arrowhead). Immunohistology, hematoxylin 
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counterstain. Figure 8. Vessels clearly dominated in some areas of the lesions. 
Immunohistology, for the demonstration of α-SMA, hematoxylin counterstain. Figure 9. 
Small amounts of predominantly thin and loosely arranged collagen (arrowheads) 
between the cells within the lesions. Van Gieson stain. Figures 10-12. Expression of 
ICAM-1 in the myocardium. Immunohistology, hematoxylin counterstain. Figure 10. 
Control heart, dog 2.2. Cardiomyocytes show weak ICAM-1 expression. Figures 11 and 
12. DCM, heart, dog 1.15. a. Cardiomyocytes show moderate ICAM-1 expression. The 
interstitial cells exhibit only very weak staining (arrowheads). b. A substantial proportion 
of the mononuclear cells in the focal lesion exhibit ICAM-1 expression (arrowheads). 
Arrows: cardiomyocytes. Figures 13-15. Expression of TGF- in the myocardium. 
Immunohistology, hematoxylin counterstain.  Figure 13. Control heart, dog 2.1. 
Cardiomyocytes show no or very weak TGF- expression. Figures 14 and 15. DCM, 
heart, dog 1.15. a. Cardiomyocytes exhibit very weak to weak TGF-β expression, 
whereas the interstitial cells are often strongly TGF-β positive (arrowheads). b. A 
substantial proportion of the mononuclear cells in the focal lesion exhibit ICAM 
expression (inset: arrowheads). Arrows: cardiomyocytes. Figures 16 and 17. DCM, 
heart, dog 1.15. Expression of VEGF in the myocardium. Immunohistology, hematoxylin 
counterstain.  Figure 16. Cardiomyocytes as well as the interstitial cells (arrowheads) 
are VEGF-negative. Figure 17. A substantial proportion of the mononuclear cells in the 
focal lesion exhibit VEGF expression (inset: arrowheads). Figures 18 and 19. DCM, 
heart, dog 1.15. Expression of the VEGF receptor Flk1 in the myocardium. 
Immunohistology, hematoxylin counterstain.  Figure 18. Cardiomyocytes exhibit 
moderate Flk1 expression, whereas the interstitial cells are Flk1 negative (arrowhead). 
Figure 19. The cells in the focal lesion are also Flk1 negative. 
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Table 1. Comparison of overall cellularity, number of interstitial small vessels, and macrophages, and percentage of area 
covered by cardiomyocytes, collagen and fibre- and cell-free interstitial space in the myocardium (right and left ventricle and 
interventricular septum) of control dogs and dogs with DCM. 
A. Comparison of the different cardiac regionsA. 
 Control DCM 
Parameters RV 
(n=5) 
IVS 
(n=5) 
LV 
(n=6) 
RV 
(n=5) 
IVS 
(n=8) 
LV 
(n=11) 
DAPI 1005 
(±319) 
10141 
(±237) 
9882 
(±298) 
744 
(±80.0) 
7601  
(±147.8) 
7682 
(±127.8) 
α-SMA 791  
(310-1066) 
926  
(411-972) 
901  
(553-947) 
706  
(512-1167) 
735  
(459-1125) 
724  
(434-1214) 
Collagen 1.53  
(1.06-2.03) 
1.051  
(0.15-1.61) 
0.952  
(0.18-1.87) 
1.91  
(1.02-8.46) 
2.291,3 
(1.12-6.62) 
4.512,3 
(1.54-12.37) 
Iba-1 59.8 
(±29.8) 
53.8 
(±26.9) 
46.61 
(±11.7) 
37.22, 3 
(±23.9) 
81.92 
(±35.1) 
83.01, 3 
(±27.1) 
Cardiomyo- 86.81 90.52 89.33 66.31 73.62, 4 63.23, 4 
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cytes (±4.4) (±3.3) (±6.1) (±12.4) (±10.4) (±7.2) 
Interstitial 
space 
11.71 
(±4.0) 
8.82 
(±3.4) 
9.73 
(±5.7) 
30.61 
(±10.5) 
24.92 
(±10.2) 
31.83 
(±6.6) 
AResults in each row that are significantly different from each other are marked by the same superscript number. Normal 
distributed results are reported as mean and standard deviation, not normal distributed data are reported as median and 
interquartile range. 
DAPI, number of cells per 20 regions of interest (ROI), based on the number of DAPI positive fluorescent nuclei; α-SMA, 
number of vessels per 20 ROIs, based on the number of α-SMA positive vascular structures; Collagen, percentage area 
occupied by VG positive fibers in 20 ROIs; Iba-1, number of macrophages per 20 ROIs, based on the number of Iba-1 
positive interstitial cells; Cardiomyocytes, percentage area occupied by cardiomyocytes in 10 ROIs in VG-stained section; 
Interstitial space, percentage area of fiber- and cell-free interstitial space in 10 ROIs in VG-stained section. 
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B. Overall assessment, based on the available data for all three cardiac regions.B 
Parameters Control 
(n=14) 
DCM 
(n=23) 
P-value 
DAPI 1002 
(±268) 
761 ↓ 
(±124) 
0.003 
α-SMA 920 
(310-1066) 
724 
(434-1214) 
0.72 
Collagen 1.17 
(0.15-2.03) 
3.08 ↑ 
(1.02-12.37) 
<0.001 
Iba-1 53.4 
(±23.1) 
73.1 ↑ 
(±33.9) 
0.038 
Cardiomyocytes 88.9 
(±4.8) 
67.3 ↓ 
(±10.2) 
<0.001 
Interstitial space 10.0 
(±4.4) 
29.2 ↑ 
(±8.9) 
<0.001 
    
38 
 
BNormal distributed results are reported as mean and standard deviation, not normal distributed data are reported as median 
and interquartile range. 
 
Abbreviations: α-SMA, α-smooth muscle actin; DAPI, 4', 6-diamidino-2-phenylindole; DCM, dilated cardiomyopathy; Iba-1, 
ionized calcium binding adaptor molecule-1; IVS, interventricular septum; LV, left ventricle; RV, right ventricle. 
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Table 2. Relative ICAM-1, cytokine and remodeling marker mRNA expression in the 
myocardium of control dogs and dogs with DCM (relative expression using the Ct value 
of the respective marker to the Ct value of GAPDH was applied, 2–ΔCt). Results are 
reported as median and interquartile range. 
 
Marker Control (n=30a) DCM (n=20a) P-value 
ICAM 298 
(107-761) 
1277 ↑ 
(255-3934) 
0.003 
IL-1 7.6 
(4.5-23.8) 
19.4 ↑ 
(11.7-32.3) 
0.012 
IL-6 10.02 
(3.23-24.2) 
71.3 
(6.97-144) 
0.075 
IL-8 47.2 
(26.1-119.4) 
232 ↑ 
(71.6-811) 
0.001 
IL-10 19.5 
(12.8-38.3) 
48.7 ↑ 
(32.1-153) 
<0.001 
TNF- 4.14 
(2.75-6.83) 
12.4 ↑ 
(3.05-19.6) 
0.019 
TGF- 3457 
(1977-4960) 
3555 
(2622-4780 
0.406 
MMP-1 1.97 
(0.3-10.9) 
2.49 
(0.2-21.2) 
0.621 
MMP-2 230 980 ↑ <0.001 
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(52.4-386.2) (318.6-2033.4) 
MMP-3 0.11 
(0.0-1.7) 
0.12 
(0.0-0.53) 
0.338 
MMP-9 9.1 
(1.5-28.6) 
3.4 
(1.6-61.6) 
0.890 
MMP-13 0.64 
(0.18-1.41) 
.37 
(0.75-3.88) 
0.053 
TIMP-1 401 
(229-1212) 
1173 ↑ 
(513-7563) 
0.002 
TIMP-2 6801 
(4783-9615) 
10510 
(5516-18408) 
0.055 
TIMP-3 18655 
(6910-27788) 
11735 
(5071-20188) 
0.075 
TIMP-4 1777 
(1325-3478) 
3347 
(1609-4878) 
0.175 
Lysyl 
oxidase 
889 
(403-1805) 
1795 ↑ 
(1078-3252) 
0.009 
 
a: represents the total number of samples (LA, RA, LV, IVS and RV) examined for this 
group. P-values indicating significant differences are in bold. 
 
Abbreviations: DCM, dilated cardiomyopathy; ICAM, intercellular adhesion molecule 1; 
IL, interleukin; MMP, matrix metalloproteinase; TGF, transforming growth factor; TIMP, 
tissue inhibitor of metalloproteinases; TNF, tumor necrosis factor.  
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Supplemental Table S1. Dogs diagnosed with DCM. Breed, age and sex, presence and distribution of histological changes 
(fatty infiltration-degenerative type (FID), attenuated wavy fiber type (AWF), focal lesions), and examinations performed in 
addition to the histological evaluation and the immunohistological staining for α-SMA and Iba-1.  
 
Case Signalment   Histopathological changes in the myocardium Further 
No Breed Age (y) Sex FID AWF Focal lesions examinations 
1.1 Great Dane 6 MN nd RA, RV RA, LV IHA, morphometryB  
1.2 Great Dane 7 M nd LV, IVS RA, LV np  
1.3 Great Dane 6 F nd RA, RV nd IH, morphometry 
1.4 Great Dane 9 FN nd RA, RV, LA LV, IVS IH, morphometry 
1.5 Great Dane 6 F nd LV, IVS LV IH, morphometry 
1.6 Great Dane 4 FN LV RA LV, IVS IH, morphometry 
1.7 Great Dane 5 M IVS RA IVS IH, morphometry 
1.8 Great Dane 4 M LV nd LV IH, morphometry 
1.9 Great Dane 7 F LV nd RA np 
1.10 Great Dane 6 M RV, LV, IVS nd RV, LA, LV, IVS IH, morphometry, qPCRC 
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1.11 Bullmastiff 7 M RV, LA, LV, IVS nd nd IH, morphometry, qPCR 
1.12 Doberman 6 FN LV nd LV IH, morphometry 
1.13 Doberman 6 M RA, RV, LA, LV nd LV IH, morphometry 
1.14 Doberman 10 FN RA, RV, LA, LV, 
IVS 
nd nd IH, morphometry, qPCR 
1.15 Doberman 8 M LV, IVS nd LV IH, morphometry, qPCR 
1.16 Doberman 7 F RA, LV, IVS nd LV, IVS IH, morphometry 
1.17 Doberman 5 FN RA, RV, LA, LV, 
IVS 
nd RA, LV, S IH, morphometry 
 
AIH: implies staining for one or more of the antigens listed in Supplemental Table S3, in addition to staining for α-SMA and 
Iba-1.  
BMorphometry: implies the morphometric assessment of van Giesson stained sections, sections stained by immunohistology 
for α-SMA and Iba-1, and sections stained with DAPI fluorescence. 
CqPCR:  implies quantitative reverse transcriptase PCR for the cytokines and remodeling enzymes listed in Table 2. 
Abbreviations: F, female; IVS, interventricular septum; LA, left atrium; LV, left ventricle; M, male; N, neutered; nd, not 
detected, np not performed, qPCR, quantitative reverse transcriptase PCR; RA, right atrium; RV, right ventricle; y, years. 
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Supplemental Table S2. Control animals, i.e. dogs that had suffered from diseases not involving the heart. Breed, age and 
sex, and examinations performed in additional to the histological evaluation and the immunohistological staining for α-SMA 
and Iba-1. 
 
Case No Breed Age (y) Sex Disease Further examinations     
2.1. Labrador 
Retriever 
0.5 M Spinal fracture due to 
road traffic accident 
IHA, morphometryB, 
qPCRD 
    
2.2 German 
Shepherd 
9 M Hemangiosarcoma 
(spleen, liver) 
IH, morphometry, qPCR     
2.3 Cocker Spaniel 8 FN Brain tumor IH, morphometry, qPCR     
2.4 Boxer 7 M Brain tumor IH, morphometry, qPCR     
2.5 Cross breed 7 FN Multicentric lymphoma Morphometry, qPCR     
2.6 Cross breed 11 FN Pancreatic carcinoma Morphometry, qPCR     
 
AIH: implies staining for one or more of the antigens listed in Supplemental Table S3, in addition to staining for α-SMA and 
Iba-1.  
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BMorphometry: implies the morphometric assessment of van Gieson stained sections, sections stained by immunohistology 
for α-SMA and Iba-1, and sections stained with DAPI fluorescence. 
CqPCR:  implies quantitative reverse transcriptase PCR for the cytokines and remodeling enzymes listed in Table 2. 
Abbreviations: F, female; IH, immunohistology; M, male; N, neutered; y, years.  
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Supplemental Table S3. Antibodies and immunohistologicaI methods, with references for their use in canine tissues. 
 
Antigen Antibody (clone) Source Dilution Pretreatment Detection 
Calprotectin6  Mouse mAb (MAC 387) Neomarkers 1:700 EDTA EnVision Mouse 
CD310 Mouse mAb (F.7.2.38) Dako  1:200 EDTA EnVision Mouse 
CD188 Mouse mAb 
(CA16.3C10) 
LABL, Davis, CA, 
USA  
1:25 Citrate EnVision Mouse 
CD202 Rabbit pAb Thermo Scientific 1:1000 n/a EnVision Rabbit 
CD317 (PECAM1) Mouse mAb (JC70A) Dako 1:20 EDTA EnVision Mouse 
Flk-111 (VEGFR-2) Mouse mAb  (A-3) Santa Cruz 1:50 EDTA EnVision Mouse 
Factor VIIIra1  Rabbit pAb Dako 1:100 Citrate EnVision Rabbit 
MHC II, HLA-DR5 Mouse mAb (TAL 1B5) Abcam 1:1500 Citrate EnVision Mouse 
Iba-14 Rabbit pAb Wako 1:750 Citrate EnVision Mouse 
ICAM-1  Mouse mAb (CL18/1D8 
or CL18/6) 
M. OyamaA  1:300 Citrate EnVision Mouse 
α-SMA3 Mouse mAb (1A4) Dako 1:400 n/a Dako REAL 
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TGF-β1 Mouse mAb (TB21) Acris 1:50 Citrate Dako REAL 
VEGF9 Goat pAb Santa Cruz 1:50 EDTA Goat HRP 
 
AThe antibody was kindly provided by Prof M. Oyama, Department of Clinical Studies, University of Pennsylvania, School of 
Veterinary Medicine. 
Abbreviations: α-SMA, α-smooth muscle actin; CD, cluster of differentiation; citrate, citrate buffer pretreatment; EDTA, EDTA 
pretreatment; Factor VIIIra, factor VIII-related antigen; Flk-1, fetal liver kinase-1; HLA-DR, human leukocyte antigen – D 
related; HRP, horseradish peroxidase; Iba-1, ionized calcium binding adaptor molecule-1; ICAM-1, intracellular adhesion 
molecule-1; LABL, Leukocyte Antigen Biology Laboratory; mAb, monoclonal antibody; MHC, major histocompatibility 
complex; n/a, not applicable; pAb, polyclonal antibody; PECAM-1, platelet endothelial cell adhesion molecule-1; TGF-β1, 
transforming growth factor-β1; VEGF, vascular endothelial growth factor; VEGFR-2, vascular endothelial growth factor 
receptor-2.  
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